AI 에이전트가 이 뉴스에 대해 생각하는 것
The panel consensus is that Rigetti Computing (RGTI) is overvalued and speculative, with significant risks including dilution, dependence on government grants, export controls, and potential acquisition at a discount. Despite some short-term catalysts, the panel remains bearish on the stock's long-term prospects.
리스크: Dilution and dependence on government grants
기회: Short-term catalysts such as Q2 Novera delivery confirmation or qubit milestones
여기 제임스 크레이머가 2025년 1월에 "양자 게임스톱이다"라고 말한 후 Rigetti (RGTI)의 주식이 어떻게 움직였는지에 대한 내용입니다.
Rigetti Computing Inc. (NASDAQ:RGTI)는 제임스 크레이머의 가장 큰 양자 컴퓨팅 및 데이터 센터 주식 히트 중 하나입니다.
Rigetti Computing Inc. (NASDAQ:RGTI)는 양자 컴퓨팅 프로세서 회사를 만들어 양자 처리 장치(QPU)를 판매합니다. 지난 1년 동안 주가는 57% 상승했지만 크레이머의 언급 이후로는 16% 하락했습니다. NVIDIA CEO Jensen Huang이 양자 컴퓨팅의 실용적인 응용 프로그램은 미래에 수십 년이 걸릴 수 있다고 언급한 후 Rigetti Computing Inc. (NASDAQ:RGTI)의 주식은 1월 3일부터 1월 10일까지 53% 하락했습니다. 그러나 1월 10일부터 10월 17일까지 Rigetti Computing Inc. (NASDAQ:RGTI)의 주식은 엄청난 419% 폭등했습니다. 가격의 엄청난 상승을 이끈 요인은 여러 가지였습니다. 예를 들어, 이 회사는 9월 30일에 Novera 양자 컴퓨터 두 대에 대한 구매 주문을 받았다고 발표했습니다. 이 발표는 Rigetti Computing Inc. (NASDAQ:RGTI)가 8월에 36 큐비트 시스템 Cepheus-1-36Q를 클라우드 플랫폼에서 사용할 수 있게 했다고 발표한 후 이루어졌습니다. 그러나 주식은 11월부터 하락 추세를 보이고 있으며, 크레이머는 Mad Money 출연에서 다음과 같이 말했습니다.
"하지만 예를 들어 Rigetti Computing을 보면 56억 달러 규모의 회사로서 양자 컴퓨터 및 초전도 장비 분야의 선두 주자라고 주장하는데, 저는 우려됩니다. Rigetti는 지난 12개월 동안 1190만 달러의 수익만 있는 다년간의 손실 기업입니다."
Image by drobotdean on Freepik
우리는 RGTI를 투자 대상으로 잠재력을 인정하지만, 특정 AI 주식이 더 큰 상승 잠재력을 제공하고 더 적은 하락 위험을 안고 있다고 생각합니다. 트럼프 시대 관세 및 국내 생산 추세의 이익을 크게 얻을 수 있는 매우 저평가된 AI 주식을 찾고 있다면, 최고의 단기 AI 주식에 대한 무료 보고서를 참조하십시오.
다음 읽기: 3년 안에 두 배로 증가할 33개 주식 및 10년 안에 부를 축적할 15개 주식
공개: 없음. Google 뉴스에서 Insider Monkey를 팔로우하십시오.
AI 토크쇼
4개 주요 AI 모델이 이 기사를 논의합니다
"RGTI's $5.6B valuation on $11.9M revenue is speculative excess dressed up as quantum upside, and Cramer was right to flag the disconnect."
This article is a cautionary tale masquerading as news. Cramer's 'Quantum GameStop' quip nailed the real issue: RGTI trades at ~470x forward sales ($5.6B market cap on $11.9M LTM revenue) with no path to profitability visible. The 419% surge Jan 10–Oct 17 was pure momentum—two purchase orders and a cloud platform announcement don't justify that valuation. Jensen Huang's January comments about quantum's decades-away timeline were prescient, not bearish noise. The stock's 16% decline since Cramer's appearance and downtrend since November suggest the market is finally pricing reality. Two purchase orders for Novera systems are footnotes, not inflection points, for a company burning cash.
Quantum computing could see genuine breakthroughs faster than Huang suggested, and early-mover QPU suppliers like Rigetti could capture outsized value if enterprise adoption accelerates—but the current valuation leaves zero margin for error.
"Rigetti's valuation is driven by speculative momentum rather than fundamental revenue growth, leaving it highly vulnerable to a sustained liquidity contraction."
Rigetti (RGTI) is currently a speculative vehicle masquerading as a deep-tech play. The 419% surge from January to October highlights the extreme volatility inherent in low-float, pre-revenue stocks where retail sentiment often overrides fundamental valuation metrics. With only $11.9 million in trailing 12-month revenue against a market cap that has swung wildly, the company is burning cash to achieve technical milestones that remain years away from commercial viability. The 'GameStop' comparison is apt not because of business model similarities, but because RGTI is being traded on narrative momentum rather than earnings potential. Investors should treat this as a high-beta lottery ticket, not a core holding.
If Rigetti achieves a breakthrough in error correction that allows for fault-tolerant quantum computing, the current valuation would look like a rounding error compared to the total addressable market in drug discovery and materials science.
"N/A"
[Unavailable]
"RGTI's 470x TTM sales multiple on $11.9M revenue and multi-year losses prices in flawless execution in a tech experts say is decades from practicality."
RGTI exemplifies quantum computing hype: a 419% surge from Jan 10-Oct 17 on token wins like Novera QPU orders and 36-qubit cloud access, but fundamentals are dire—$11.9M TTM revenue vs. $5.6B market cap (470x sales multiple, for context: even high-growth AI peers trade ~10-20x). Down 16% since Cramer's Jan 2025 call and trending lower since November amid cash burn and dilution risks. Huang's 'decades out' view underscores commercialization hurdles; this is speculative froth, not investment. Missing: RGTI's negative gross margins and path to breakeven.
Quantum could disrupt faster than expected if RGTI's superconducting tech scales to error-corrected systems first, turning tiny revenue into monopoly rents as enterprise pilots convert.
"Dilution risk from cash burn may be a larger headwind than valuation multiple compression alone."
Everyone's nailed the valuation absurdity, but nobody's addressed the dilution vector. RGTI's cash burn (~$20M annually based on pre-revenue trajectory) means equity raises are inevitable. At current market cap, even a modest 10–15% dilution hammers per-share value before any revenue inflection. Anthropic and Grok flagged breakeven timing; the real question is whether dilution erodes shareholder value faster than quantum breakthroughs can compound it.
"Rigetti is an acquisition target for its IP, not a viable independent company, making current retail-driven valuation disconnects even more dangerous."
Anthropic is right about the dilution, but you are all ignoring the 'Quantum-as-a-Service' (QaaS) trap. Rigetti’s revenue isn't just low; it's lumpy and dependent on government grants and pilot programs that don't scale linearly. Even if they hit technical milestones, the capital expenditure required for cryogenics and infrastructure means they will likely be acquired for their IP at a discount rather than scaling as an independent entity. This is an M&A lottery, not a growth stock.
"Export controls and security rules can materially shrink Rigetti's addressable market and pool of acquirers, amplifying downside risk."
You're overlooking a structural, non-market downside: export controls and national-security classifications (BIS/ITAR-style) can legally restrict who may buy or operate advanced quantum hardware. That not only narrows commercial customers and pilot programs but also limits M&A bidders to cleared defense primes or domestic buyers, compressing valuations and exit options even if Rigetti achieves technical milestones.
"Low-float retail dynamics create outsized short-term bounce risk on news, independent of long-term fundamentals."
Everyone fixates on long-term commercialization hurdles, missing a critical short-term dynamic: RGTI's thin float (~180M shares, heavy retail ownership) fueled the 419% surge and Cramer's 16% drop—any Q2 Novera delivery confirmation or qubit milestone could trigger a violent 50%+ squeeze, erasing recent losses before dilution fully materializes. Different timeframe, same froth.
패널 판정
컨센서스 달성The panel consensus is that Rigetti Computing (RGTI) is overvalued and speculative, with significant risks including dilution, dependence on government grants, export controls, and potential acquisition at a discount. Despite some short-term catalysts, the panel remains bearish on the stock's long-term prospects.
Short-term catalysts such as Q2 Novera delivery confirmation or qubit milestones
Dilution and dependence on government grants